Yiling Meng
Impact in
-
- Cancer Genomics and Diagnostics
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 6
- Cancer-related Molecular Pathways 3
-
- Cancer Genomics and Diagnostics 1
- Co-authors
- Meichao Zhang (9 shared papers)Lei Bian (6 shared papers)Dong Li (4 shared papers)Jian Wu (3 shared papers)Cao Hongcui (2 shared papers)Jiong Yu (2 shared papers)Lanjuan Li (2 shared papers)Bin Jiang (2 shared papers)
In The Last Decade
Yiling Meng
19 papers receiving 450 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 68
- Oncology 120
- Molecular Biology 221
- Hepatology 19
- Otorhinolaryngology 9
Countries citing papers authored by Yiling Meng
This map shows the geographic impact of Yiling Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiling Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiling Meng more than expected).
Fields of papers citing papers by Yiling Meng
This network shows the impact of papers produced by Yiling Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiling Meng. The network helps show where Yiling Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiling Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 200 | |
| 2 | 2020 | 39 | |
| 3 | 2020 | 37 | |
| 4 | 2020 | 29 | |
| 5 | 2022 | 22 | |
| 6 | 2023 | 22 | |
| 7 | 2020 | 20 | |
| 8 | 2022 | 14 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 12 | |
| 11 | 2021 | 11 | |
| 12 | 2024 | 11 | |
| 13 | 2023 | 8 | |
| 14 | 2023 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2024 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2023 | 0 |
About Yiling Meng
Yiling Meng is a scholar working on Oncology, Cancer Research, Molecular Biology, Hepatology and Immunology, having authored 20 papers that have together received 455 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), DNA Repair Mechanisms (3 papers), Hepatitis Viruses Studies and Epidemiology (2 papers), RNA modifications and cancer (2 papers), Liver Disease and Transplantation (2 papers), Immunotherapy and Immune Responses (2 papers), Nanoplatforms for cancer theranostics (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (68 citations), Oncology (120 citations), Molecular Biology (221 citations), Hepatology (19 citations) and Otorhinolaryngology (9 citations). Yiling Meng has collaborated with scholars based in China and Sweden. Frequent co-authors include Meichao Zhang, Lei Bian, Dong Li, Jian Wu, Cao Hongcui, Jiong Yu, Lanjuan Li, Bin Jiang, Xiao Lu and Fu-Rao Liu. Their work appears in journals such as ACS Applied Materials & Interfaces, Epigenomics, International Journal of Biological Sciences, Journal of Viral Hepatitis and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.